0
ARTICLE |

STUDIES IN THE CHEMOTHERAPY OF BACTERIAL INFECTIONS:  II. THE CHEMOTHERAPY OF EXPERIMENTAL LOCALIZED BACTERIAL INFECTIONS WITH SPECIAL REFERENCE TO PLEURITIS

JOHN A. KOLMER, M.D.
Arch Intern Med (Chic). 1923;31(1):9. doi:10.1001/archinte.1923.00110130012002.
Text Size: A A A
Published online

In serum and chemotherapeutic investigations in bacterial infections, animals are usually infected by subcutaneous or intraperitoneal injections of the test microorganism resulting in the production of generalized infections associated with bacteremia and terminating fatally in a few days, or in a few weeks, as in experimental tuberculosis. As a general rule, the test animals are very susceptible to the test microparasite, and the results are evaluated by the duration of the lives of treated animals as compared with infected but untreated controls.

In experimental serum therapy of such bacterial infections as are produced by virulent pneumococci, streptococci, meningococci, anthrax bacilli, and so forth, this method is generally satisfactory because owing to the low toxicity of the immune serums for the test animals, relatively large amounts may be given to influence favorably an otherwise rapidly fatal bacteremia and septicemia. But in chemotherapeutic studies in bacterial infections the dosis curativa of a

Topics

Sign In to Access Full Content

Don't have Access?

Register and get free email Table of Contents alerts, saved searches, PowerPoint downloads, CME quizzes, and more

Subscribe for full-text access to content from 1998 forward and a host of useful features

Activate your current subscription (AMA members and current subscribers)

Purchase Online Access to this article for 24 hours

First Page Preview

View Large
First page PDF preview

Figures

Tables

Interactive Graphics

Video

Country-Specific Mortality and Growth Failure in Infancy and Yound Children and Association With Material Stature

Use interactive graphics and maps to view and sort country-specific infant and early dhildhood mortality and growth failure data and their association with maternal

References

Correspondence

CME
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.
NOTE:
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s “Cited By” API will populate this tab (http://www.crossref.org/citedby.html).
Submit a Comment

Some tools below are only available to our subscribers or users with an online account.

Sign In to Access Full Content

Related Content

Customize your page view by dragging & repositioning the boxes below.

Jobs